A Colorimetric Assay That Specifically Measures Granzyme B Proteolytic Activity: Hydrolysis of Boc-Ala-Ala-Asp-S-Bzl

Overview

Journal J Vis Exp

Specialties Biology
General Medicine

Date 2014 Dec 10

PMID 25489668

Citations 3

Authors

Magdalena Hagn

Vivien R Sutton

Joseph A Trapani

Affiliations

Soon will be listed here.

Abstract

The serine protease Granzyme B (GzmB) mediates target cell apoptosis when released by cytotoxic T lymphocytes (CTL) or natural killer (NK) cells. GzmB is the most studied granzyme in humans and mice and therefore, researchers need specific and reliable tools to study its function and role in pathophysiology. This especially necessitates assays that do not recognize proteases such as caspases or other granzymes that are structurally or functionally related. Here, we apply GzmB's preference for cleavage after aspartic acid residues in a colorimetric assay using the peptide thioester Boc-Ala-Ala-Asp-S-Bzl. GzmB is the only mammalian serine protease capable of cleaving this substrate. The substrate is cleaved with similar efficiency by human, mouse and rat GzmB, a property not shared by other commercially available peptide substrates, even some that are advertised as being suitable for this purpose. This protocol is demonstrated using unfractionated lysates from activated NK cells or CTL and is also suitable for recombinant proteases generated in a variety of prokaryotic and eukaryotic systems, provided the correct controls are used. This assay is a highly specific method to ascertain the potential pro-apoptotic activity of cytotoxic molecules in mammalian lymphocytes, and of their recombinant counterparts expressed by a variety of methodologies.

Citing Articles

Death and survival of gut CD4 T cells following HIV-1 infection ex vivo.

Mickens K, Dillon S, Guo K, Thompson A, Barrett B, Wood C PNAS Nexus. 2025; 3(11):pgae486.

PMID: 39780917 PMC: 11707799. DOI: 10.1093/pnasnexus/pgae486.

Pharmacologic inhibition of dipeptidyl peptidase 1 (cathepsin C) does not block granzyme-mediated target cell killing by CD8 T or NK cells.

Sutton V, Watt S, Akhlaghi H, Cipolla D, Chen K, LaSala D Front Pharmacol. 2024; 15:1396710.

PMID: 39021839 PMC: 11251990. DOI: 10.3389/fphar.2024.1396710.

Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity.

Hay Z, Slansky J Int J Mol Sci. 2022; 23(3).

PMID: 35163755 PMC: 8836949. DOI: 10.3390/ijms23031833.

A High Yield and Cost-efficient Expression System of Human Granzymes in Mammalian Cells.

Dotiwala F, Fellay I, Filgueira L, Martinvalet D, Lieberman J, Walch M J Vis Exp. 2015; (100):e52911.

PMID: 26132420 PMC: 4544413. DOI: 10.3791/52911.

References

Hagn M, Jahrsdorfer B . Why do human B cells secrete granzyme B? Insights into a novel B-cell differentiation pathway. Oncoimmunology. 2012; 1(8):1368-1375. PMC: 3518509. DOI: 10.4161/onci.22354. View

Sutton V, Waterhouse N, Browne K, Sedelies K, Ciccone A, Anthony D . Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis. J Cell Biol. 2007; 176(4):425-33. PMC: 2063978. DOI: 10.1083/jcb.200609077. View

Hagn M, Schwesinger E, Ebel V, Sontheimer K, Maier J, Beyer T . Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J Immunol. 2009; 183(3):1838-45. DOI: 10.4049/jimmunol.0901066. View

Bots M, Medema J . Serpins in T cell immunity. J Leukoc Biol. 2008; 84(5):1238-47. DOI: 10.1189/jlb.0208140. View

Bird C, Sutton V, Sun J, Hirst C, Novak A, Kumar S . Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol. 1998; 18(11):6387-98. PMC: 109224. DOI: 10.1128/MCB.18.11.6387. View

Trapani J, Smyth M, Apostolidis V, Dawson M, Browne K . Granule serine proteases are normal nuclear constituents of natural killer cells. J Biol Chem. 1994; 269(28):18359-65. View

Susanto O, Trapani J, Brasacchio D . Controversies in granzyme biology. Tissue Antigens. 2012; 80(6):477-87. DOI: 10.1111/tan.12014. View

Hoves S, Trapani J, Voskoboinik I . The battlefield of perforin/granzyme cell death pathways. J Leukoc Biol. 2009; 87(2):237-43. DOI: 10.1189/jlb.0909608. View

Ewen C, Kane K, Bleackley R . A quarter century of granzymes. Cell Death Differ. 2011; 19(1):28-35. PMC: 3252830. DOI: 10.1038/cdd.2011.153. View

10.

Sutton V, Davis J, Cancilla M, Johnstone R, Ruefli A, Sedelies K . Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation. J Exp Med. 2000; 192(10):1403-14. PMC: 2193191. DOI: 10.1084/jem.192.10.1403. View

11.

Bird C, Hitchen C, Prescott M, Harper I, Bird P . Immunodetection of granzyme B tissue distribution and cellular localisation. Methods Mol Biol. 2012; 844:237-50. DOI: 10.1007/978-1-61779-527-5_17. View

12.

Kaiserman D, Bird C, Sun J, Matthews A, Ung K, Whisstock J . The major human and mouse granzymes are structurally and functionally divergent. J Cell Biol. 2006; 175(4):619-30. PMC: 2064598. DOI: 10.1083/jcb.200606073. View

13.

Casciola-Rosen L, Garcia-Calvo M, Bull H, Becker J, Hines T, Thornberry N . Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the bid pathway. J Biol Chem. 2006; 282(7):4545-4552. DOI: 10.1074/jbc.M606564200. View

14.

Cullen S, Adrain C, Luthi A, Duriez P, Martin S . Human and murine granzyme B exhibit divergent substrate preferences. J Cell Biol. 2007; 176(4):435-44. PMC: 2063979. DOI: 10.1083/jcb.200612025. View

15.

Odake S, Kam C, Narasimhan L, Poe M, Blake J, Krahenbuhl O . Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry. 1991; 30(8):2217-27. DOI: 10.1021/bi00222a027. View

16.

Thornberry N, Rano T, Peterson E, Rasper D, Timkey T, Garcia-Calvo M . A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem. 1997; 272(29):17907-11. DOI: 10.1074/jbc.272.29.17907. View

17.

Trapani J, Browne K, Dawson M, Smyth M . Immunopurification of functional Asp-ase (natural killer cell granzyme B) using a monoclonal antibody. Biochem Biophys Res Commun. 1993; 195(2):910-20. DOI: 10.1006/bbrc.1993.2131. View

18.

Hagn M, Belz G, Kallies A, Sutton V, Thia K, Tarlinton D . Activated mouse B cells lack expression of granzyme B. J Immunol. 2012; 188(8):3886-92. DOI: 10.4049/jimmunol.1103285. View

19.

Strik M, de Koning P, Kleijmeer M, Bladergroen B, Wolbink A, Griffith J . Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. Mol Immunol. 2007; 44(14):3462-72. DOI: 10.1016/j.molimm.2007.03.024. View

20.

POWERS J, Kam C . Peptide thioester substrates for serine peptidases and metalloendopeptidases. Methods Enzymol. 1995; 248:3-18. DOI: 10.1016/0076-6879(95)48003-x. View